Bluejay Diagnostics (BJDX) Equity Ratio (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed Equity Ratio for 2 consecutive years, with 0.63 as the latest value for Q3 2023.
- Quarterly Equity Ratio fell 28.11% to 0.63 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 0.63 through Sep 2023, down 28.11% year-over-year, with the annual reading at 0.85 for FY2022, N/A changed from the prior year.
- Equity Ratio hit 0.63 in Q3 2023 for Bluejay Diagnostics, down from 0.75 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.92 in Q2 2022 to a low of 0.63 in Q3 2023.